Dual pharmacological targeting of hdacs and pde5 inhibits liver disease progression in a mouse model of biliary inflammation and fibrosis

  1. Claveria-Cabello, A.
  2. Colyn, L.
  3. Uriarte, I.
  4. Ujue Latasa, M.
  5. Arechederra, M.
  6. Herranz, J.M.
  7. Alvarez, L.
  8. Urman, J.M.
  9. Martinez-Chantar, M.L.
  10. Banales, J.M.
  11. Sangro, B.
  12. Rombouts, K.
  13. Oyarzabal, J.
  14. Marin, J.J.G.
  15. Berasain, C.
  16. Avila, M.A.
  17. Fernandez-Barrena, M.G.
Journal:
Cancers

ISSN: 2072-6694

Year of publication: 2020

Volume: 12

Issue: 12

Pages: 1-27

Type: Article

DOI: 10.3390/CANCERS12123748 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals